黄色直播

 

Molly Appeal to help fund Orbitrap Fusion, boosting cancer, brain, immunity research

- October 7, 2019

Dr. Shashi Gujar and his research team, left to right, Prathyusha Konda, Youra Kim (PhD Students), Dr. Shashi Gujar and Dr. Barry Kennedy (Post-Doctoral Fellow) will use equipment purchased through the fall 2019 Molly Appeal to pioneer new cancer immune therapies. (Photo courtesy 黄色直播 Medical Research Foundation)
Dr. Shashi Gujar and his research team, left to right, Prathyusha Konda, Youra Kim (PhD Students), Dr. Shashi Gujar and Dr. Barry Kennedy (Post-Doctoral Fellow) will use equipment purchased through the fall 2019 Molly Appeal to pioneer new cancer immune therapies. (Photo courtesy 黄色直播 Medical Research Foundation)

黄色直播 will soon be home to Atlantic Canada鈥檚 only Orbitrap Fusion mass spectrometer, a powerful research instrument that will allow researchers to explore new territory in their search for cures for cancer, infectious diseases, autoimmune disorders, neurodegenerative diseases, psychiatric illnesses and many more deadly and debilitating conditions.

Maritimers can help by donating to 黄色直播 Medical Research Foundation鈥檚 2019 fall , which aims to raise $250,000 in cornerstone funds for the $1.3 million machine. Federal and provincial government agencies, 黄色直播鈥檚 Faculty of Medicine and 黄色直播 Medical Research Foundation will supply the rest of the necessary funds.

Researchers like Dr. Shashi Gujar will use the Orbitrap Fusion to analyze proteins and metabolites inside cells, rapidly and with 50 to 100 times greater sensitivity and detail than current equipment allows.

鈥淭he new Orbitrap Fusion features all the latest advances in mass spectrometry and will accelerate research in all areas of 黄色直播鈥檚 Faculty of Medicine, the university at large, and even eastern Canada,鈥 says Dr. Gujar, an assistant professor in the departments of Pathology and Microbiology & Immunology.

Cancer immunotherapy


Dr. Gujar is gaining international attention for his efforts to fight cancer with such strategies as cancer-killing viruses and light-activated ruthenium compounds that 鈥渇lag鈥 cancer cells so the immune system can see and then kill them. And since the Orbitrap Fusion mass spectrometer is equipped to identify and measure the by-products of metabolism inside cells, it will allow him to pursue his world-leading efforts to find the best ways of starving cancer cells.

鈥淐ancer requires a lot of fuel to sustain its growth,鈥 says Dr. Gujar. 鈥淲e are the first to discover that manipulating the metabolism of cancer 鈥 for example, by inhibiting enzymes that fuel cancer growth 鈥 makes cancers highly susceptible to destruction by cancer-killing viruses and other therapies. The Orbitrap Fusion is essential to our progress in this work.鈥


Dr. Alejandro Cohen and Dr. James Fawcett will make extensive use of the Orbitrap Fusion, which will replace the mass spectrometer鈥攂ased on 20-year-old technology鈥攕hown here. (Photo courtesy 黄色直播 Medical School)

Personalized medicine


The ability to see what metabolites are present in blood and tissue samples opens the door to new ways of diagnosing illness and predicting a patient鈥檚 response to treatment, according to Dr. James Fawcett, a professor in the departments of Pharmacology and Surgery and an expert in mass spectrometry. As he notes, 鈥淚t provides a whole new way to develop treatments that can be personalized to the specific needs of individual patients.鈥

Dr. Fawcett will use the Orbitrap Fusion in his work to understand the genetic mutations that lead to psychiatric disorders, such as schizophrenia and bipolar disorder. 鈥淕enetic mutations lead to structural and functional defects in the proteins that are important for synaptic connections within the brain,鈥 he explains. 鈥淭he new equipment will allow us to understand how bipolar disorder and schizophrenia develop and to identify and test potential new therapies for these devastating mental illnesses.鈥

At the same time, Dr. Fawcett is working with colleagues in 黄色直播鈥檚 Faculty of Medicine to explore potential new immune therapies for cancer. For example, he and Dr. Carman Giacomantonio are investigating immunotherapies for skin cancers, while he and Dr. Adrienne Weeks are exploring potential immune therapies for glioblastoma, a deadly form of brain cancer.

鈥淢ass spectrometry is a powerful tool we use to identify complexes of proteins that work together and how they can change in diseases,鈥 Dr. Fawcett says. 鈥淢ass spectrometry is a powerful tool for understanding illness, designing drugs, diagnosing disease, fine-tuning a treatment plan, and monitoring response to treatment.鈥

Accelerated regional progress


The Orbitrap Fusion mass spectrometer will replace aging equipment based on 20-year-old technology. More than 60 research groups at 黄色直播 and across the region have made use of the old equipment since 2015. Many projects will move forward, and faster, with the addition of the Orbitrap Fusion and the new capabilities it will bring.

The new equipment will be housed in the 黄色直播 Faculty of Medicine Mass Spectrometry and Proteomics Core Facility, maintained and operated by trained experts and accessible to researchers around the clock, so they can accelerate their efforts to find cures. The instrument will also enhance the research training environment for the broader community and promote collaborations with industry and government researchers in Atlantic Canada.

For more information and to give to the Molly Appeal, visit